Blue Trust Inc. boosted its holdings in Chemed Co. (NYSE:CHE – Free Report) by 2.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,921 shares of the company’s stock after buying an additional 46 shares during the period. Blue Trust Inc.’s holdings in Chemed were worth $1,018,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in shares of Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Trust Co. of Vermont acquired a new position in shares of Chemed in the 4th quarter valued at about $34,000. American National Bank & Trust acquired a new position in shares of Chemed in the 3rd quarter valued at about $61,000. GAMMA Investing LLC lifted its stake in shares of Chemed by 60.5% in the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock valued at $83,000 after purchasing an additional 52 shares in the last quarter. Finally, Quarry LP lifted its stake in shares of Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on the company. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada dropped their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a report on Tuesday, November 5th.
Chemed Stock Performance
Shares of NYSE:CHE opened at $561.15 on Wednesday. The company has a market cap of $8.45 billion, a P/E ratio of 28.36, a PEG ratio of 2.15 and a beta of 0.47. Chemed Co. has a one year low of $512.12 and a one year high of $654.62. The business’s 50-day simple moving average is $544.91 and its 200 day simple moving average is $563.91.
Chemed (NYSE:CHE – Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The business had revenue of $606.18 million for the quarter, compared to analysts’ expectations of $612.22 million. During the same quarter in the prior year, the firm earned $5.32 earnings per share. Chemed’s revenue for the quarter was up 7.4% compared to the same quarter last year. Analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.
Chemed Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a dividend of $0.50 per share. The ex-dividend date was Monday, November 18th. This represents a $2.00 annualized dividend and a yield of 0.36%. Chemed’s dividend payout ratio is presently 10.11%.
Insiders Place Their Bets
In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now directly owns 101,735 shares in the company, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the sale, the executive vice president now owns 18,287 shares in the company, valued at $10,526,362.94. This represents a 3.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is owned by company insiders.
Chemed Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories
- Five stocks we like better than Chemed
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Invest in the Best Canadian Stocks
- What Does the Future Hold for Eli Lilly?
- Market Cap Calculator: How to Calculate Market Cap
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.